SpyGlass Pharma, Inc. (SGP)
24.00
-0.72
(-2.91%)
USD |
NASDAQ |
Oct 16, 16:00
24.16
+0.16
(+0.67%)
After-Hours: 20:00
SpyGlass Pharma Net Income (Quarterly) : -19.86M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -19.86M |
| March 31, 2026 | -13.82M |
| December 31, 2025 | -12.56M |
| Date | Value |
|---|---|
| June 30, 2025 | -8.675M |
| March 31, 2025 | -8.823M |
| December 31, 2024 | -8.399M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 19.86M |
| EPS Diluted (Quarterly) | -0.5939 |
| Enterprise Value | 570.16M |
| Earnings Yield | -8.01% |
| Normalized Earnings Yield | -8.01 |